| Literature DB >> 35480316 |
Almas Jabeen1, Nadeem Ahmad1, Khalid Raza2.
Abstract
Coronavirus is an enclosed positive-sense RNA virus with club-like spikes protruding from its surface that causes acute respiratory infections in humans. Because it is considered a member of the complex pathogen group, it has been found to infect different host species and cause a variety of diseases. So far, it has been discovered that it may affect the immune, infection, and inflammatory systems, leading to the hypothesis that the immune and inflammatory systems (signaling pathways and components) fail to control infection, opening the door to look for potential targets primarily in these systems. The study's main purpose is to identify highly overexpressed genes and their functional implications as a result of COVID-19 infection, as well as to investigate probable infections, inflammation, and immune systems to better understand the impact of coronavirus infection. We explored the genes and pathways mostly linked with infection, inflammation, and the immune systems using the datasets available for COVID-19 infection gene expression compendium. NFKBIA, FN1, FAP, KANK4, COMP, FAM101B, COL1A2, ANKRD1, TAGLN, SPARC, ADAM19, OLFM4, CXCL10/11, OASL, FOS, APOBEC3A, IFI44L, IFI27, IFIT1, RSAD2, NDUFS1, SRSF6, HECTD1, CBX3, and DDX17 are among the genes that may be impacted by infection, according to our findings. The functional changes are mainly associated with these pathways TNF, cytokine, NF-kB, TLR, TCR, BCR, Foxo, and TGF signaling pathways are among them and there are additional pathways such as hippo signaling, apoptosis, estrogen signaling, regulating pluropotency of stem cells, ErbB, Wnt, p53, cAMP, MAPK, PI3K-AKT, oxidative phosphorylation, protein processing in endoplasmic reticulum, prolactin signaling, adipocytokine, neurotrophine signaling, and longevity regulating pathways. Moreover, we have also explored the potential herbal drug (apigenin, quercetin, and resveratrol) targets for the top-rated genes based on the overall analysis where we observe that quercetin and resveratrol as most effective.Entities:
Keywords: coronavirus; differentially expressed genes network; gene expression profiling; infection and immune system; pathological biomarkers
Year: 2022 PMID: 35480316 PMCID: PMC9035897 DOI: 10.3389/fgene.2022.870836
Source DB: PubMed Journal: Front Genet ISSN: 1664-8021 Impact factor: 4.772
FIGURE 1Gene expression profiling and enriched pathways. Top-ranked 50 DGEs based on fold changes and p-values at different infection time period (A) 12 h, (B) 24 h, and (C) 48 h.
FIGURE 2DEGs network and their respective fold changes and p-values. (A) Venn diagram followed by the DEGs network, (B) DEGs (181 genes shared between 24 and 48 h) with their fold changes, (C) the enriched KEGG pathways followed by the venn diagram to display the alterations at different time points.
Enriched pathways for GSE183071 COVID-19 dataset DEGs.
| Enriched Pathways |
|
|---|---|
| KEGG_04010_MAPK_signaling_pathway | 5.42E-20 |
| KEGG_04060_Cytokine-cytokine_receptor_interaction | 5.42E-20 |
| KEGG_04064_NF-kappa_B_signaling_pathway_-_Homo_sapiens_(human) | 5.42E-20 |
| KEGG_04145_Phagosome | 5.42E-20 |
| KEGG_04151_PI3K-Akt_signaling_pathway_-_Homo_sapiens_(human) | 5.42E-20 |
| KEGG_04210_Apoptosis | 5.42E-20 |
| KEGG_04380_Osteoclast_differentiation | 5.42E-20 |
| KEGG_04514_Cell_adhesion_molecules_(CAMs) | 5.42E-20 |
| KEGG_04612_Antigen_processing_and_presentation | 5.42E-20 |
| KEGG_04620_Toll-like_receptor_signaling_pathway | 5.42E-20 |
| KEGG_04630_Jak-STAT_signaling_pathway | 5.42E-20 |
| KEGG_04640_Hematopoietic_cell_lineage | 5.42E-20 |
| KEGG_04650_Natural_killer_cell_mediated_cytotoxicity | 5.42E-20 |
| KEGG_04660_T_cell_receptor_signaling_pathway | 5.42E-20 |
| KEGG_04662_B_cell_receptor_signaling_pathway | 5.42E-20 |
| KEGG_04668_TNF_signaling_pathway_-_Homo_sapiens_(human) | 5.42E-20 |
| KEGG_04068_FoxO_signaling_pathway_-_Homo_sapiens_(human) | 4.11E-19 |
| KEGG_04722_Neurotrophin_signaling_pathway | 4.11E-19 |
| KEGG_04917_Prolactin_signaling_pathway | 1.56E-16 |
| KEGG_04920_Adipocytokine_signaling_pathway | 1.56E-16 |
| KEGG_04015_Rap1_signaling_pathway_-_Homo_sapiens_(human) | 4.78E-14 |
| KEGG_04810_Regulation_of_actin_cytoskeleton | 4.78E-14 |
| KEGG_04014_Ras_signaling_pathway_-_Homo_sapiens_(human) | 7.65E-13 |
| KEGG_04066_HIF-1_signaling_pathway_-_Homo_sapiens_(human) | 7.65E-13 |
| KEGG_04670_Leukocyte_transendothelial_migration | 7.65E-13 |
| KEGG_04071_Sphingolipid_signaling_pathway_-_Homo_sapiens_(human) | 1.15E-11 |
| KEGG_04510_Focal_adhesion | 1.15E-11 |
| KEGG_04621_NOD-like_receptor_signaling_pathway | 1.15E-11 |
| KEGG_04550_Signaling_pathways_regulating_pluripotency_of_stem_cells | 1.61E-10 |
| KEGG_04610_Complement_and_coagulation_cascades | 1.61E-10 |
| KEGG_04622_RIG-I-like_receptor_signaling_pathway | 1.61E-10 |
| KEGG_04370_VEGF_signaling_pathway | 2.09E-09 |
| KEGG_04611_Platelet_activation | 2.09E-09 |
| KEGG_04672_Intestinal_immune_network_for_IgA_production | 1.58E-08 |
| KEGG_04664_Fc_epsilon_RI_signaling_pathway | 2.51E-08 |
| KEGG_04115_p53_signaling_pathway | 2.76E-07 |
| KEGG_04360_Axon_guidance | 2.76E-07 |
| KEGG_04919_Thyroid_hormone_signaling_pathway | 2.76E-07 |
| KEGG_04921_Oxytocin_signaling_pathway | 2.76E-07 |
| KEGG_04012_ErbB_signaling_pathway | 2.76E-06 |
| KEGG_04072_Phospholipase_D_signaling_pathway_-_Homo_sapiens_(human) | 2.48E-05 |
| KEGG_04310_Wnt_signaling_pathway | 2.48E-05 |
| KEGG_04350_TGF-beta_signaling_pathway | 2.48E-05 |
| KEGG_04392_Hippo_Signaling_Pathway | 2.48E-05 |
| KEGG_04520_Adherens_junction | 2.48E-05 |
| KEGG_04750_Inflammatory_mediator_regulation_of_TRP_channels | 2.48E-05 |
| KEGG_04623_Cytosolic_DNA-sensing_pathway | 1.08E-04 |
| KEGG_04110_Cell_cycle | 1.98E-04 |
| KEGG_04512_ECM-receptor_interaction | 1.98E-04 |
| KEGG_04912_GnRH_signaling_pathway | 1.98E-04 |
| KEGG_03050_Proteasome | 1.39E-03 |
| KEGG_04024_cAMP_signaling_pathway_-_Homo_sapiens_(human) | 1.39E-03 |
| KEGG_04211_Longevity_regulating_pathway | 1.39E-03 |
| KEGG_04540_Gap_junction | 1.39E-03 |
| KEGG_04666_Fc_gamma_R-mediated_phagocytosis | 1.39E-03 |
| KEGG_04910_Insulin_signaling_pathway | 1.39E-03 |
| KEGG_04915_Estrogen_signaling_pathway | 1.39E-03 |
| KEGG_00230_Purine_metabolism | 8.33E-03 |
| KEGG_04022_cGMP-PKG_signaling_pathway_-_Homo_sapiens_(human) | 8.33E-03 |
| KEGG_04120_Ubiquitin_mediated_proteolysis | 8.33E-03 |
| KEGG_04140_Regulation_of_autophagy | 8.33E-03 |
| KEGG_04141_Protein_processing_in_endoplasmic_reticulum | 8.33E-03 |
| KEGG_04371_Apelin_signaling_pathway_-_Homo_sapiens_(human) | 8.33E-03 |
| KEGG_04916_Melanogenesis | 8.33E-03 |
| KEGG_04020_Calcium_signaling_pathway | 4.17E-02 |
| KEGG_04080_Neuroactive_ligand-receptor_interaction | 4.17E-02 |
| KEGG_04144_Endocytosis | 4.17E-02 |
| KEGG_04261_Adrenergic_signaling_in_cardiomyocytes | 4.17E-02 |
| KEGG_04530_Tight_junction | 4.17E-02 |
| KEGG_04723_Retrograde_endocannabinoid_signaling | 4.17E-02 |
| KEGG_04914_Progesterone-mediated_oocyte_maturation | 4.17E-02 |
FIGURE 3Docking profiling. Here, the docking has been performed by using the three herbal drugs (apigenin, quercetin, and resveratrol) against the top five genes.